http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6231029-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7046c648afc634bdbba4897a58c8fd9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20 |
| filingDate | 2009-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d1f27d8f48365497918bb4257e68132 |
| publicationDate | 2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-6231029-A2 |
| titleOfInvention | DERIVATIVES OF ARILDIMETHYLPIRAZOLONE TO REDUCE ANTISTETIC CELLULITIS AND COSMETIC COMPOSITIONS CONTAINING IT |
| abstract | 1.- The compound 5- {4- [2- (4-fluoro-benzyl) -3-oxo-cyclohex-1-enylamin] -2,3-difluoro-phenyl} -4,4-dimethyl-2,4 -dihydro-pyrazol-3-one with formula (I): and its cosmetically acceptable salts. 2. A cosmetic composition for topical administration containing the compound with formula (I), or a cosmetically acceptable salt thereof, as defined in claim 1, for the treatment of cellulite. 3. The composition according to claim 2, further characterized in that it contains the compound with formula (I) at the concentration of 0.1 to 2% by weight. 4. The composition according to claim 3, further characterized in that it contains the compound with formula (I) at the concentration of 0.1 to 1% by weight. 5.- The composition according to claim 4, further characterized in that it contains the compound with formula (I) at the concentration of 0.2 to 0.5% by weight.6.- The composition according to claims 2-5, further characterized in that it is in the form of a gel, spray gel, cream, non-greasy cream , oil-free or ointment formulations. 7. The composition according to claims 1 to 6, further characterized in that it also contains a saponin and / or a flavone selected from escina or extracts of Ginkgo biloba, arnica, pineapple, dong quai ( Angelica siniensis) and Centella asiatica. 8. The cosmetic composition according to claims 1-7, further characterized in that it also contains a polyunsaturated omega-3 fatty acid selected from acid 1 0-trans-12-cis linoleic acid and docosahexenoic acid. 9. The use of a compound as defined in claim 1 for the cosmetic treatment of cellulite. |
| priorityDate | 2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.